Financials

	2022	2023
Net sales	0.19 0.13 0.13 0.12 0.11 11.36 0.21 1.46 0.54 4.67 0.5 0.49 20.11	0.25 0.18 0.17 0.16 0.14 14.99 0.28 1.93 0.71 6.16 0.67 0.65 26.54
Net income	-8.52M -6.03M -5.7M -5.29M -4.73M -510M -9.43M -65.78M -24.32M -210M -22.64M -22.14M -904M	-300K -212K -201K -186K -166K -17.97M -332K -2.32M -856K -7.38M -797K -779K -31.81M
Net Debt	-680K -481K -455K -422K -377K -40.74M -753K -5.25M -1.94M -16.74M -1.81M -1.77M -72.13M	-345K -244K -231K -214K -191K -20.64M -382K -2.66M -984K -8.48M -916K -895K -36.55M

More financial data * Estimated data

Company Profile

Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is interested in treating addiction and substance-use disorders.

Employees

Sector

Biotechnology & Medical Research

Calendar

2024-12-16 - Annual General Meeting

More about the company

Quotes

Date	Price	Change	Volume
24-12-06	0.1750 $	+9.37%	20,540
24-12-05	0.1600 $	+14.29%	129,000
24-12-04	0.1400 $	+3.70%	118,100
24-12-03	0.1350 $	0.00%	39,500
24-12-02	0.1350 $	-3.57%	7,600

Delayed Quote Canadian Securities Exchange, December 06, 2024 at 03:58 pm EST

More quotes

Income Statement and Estimates

income-statement-evolution-chart ENTHEON-BIOMEDICAL-CORP

More financial data

Market Closed - Canadian Securities Exchange Other stock markets 03:58:53 2024-12-06 pm EST			5-day change	1st Jan Change
0.1750 ^CAD	+9.38%		+25.00%	+75.00%

Dec. 02	Entheon Biomedical Corp. announced that it expects to receive CAD 0.3 million in funding	CI
Oct. 24	Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024	CI

Capitalization	1.24M 877K 830K 770K 688K 74.29M 1.37M 9.58M 3.54M 30.52M 3.3M 3.22M 132M	P/E ratio 2022	-0.21x	P/E ratio 2023	-1.97x
Enterprise value	896K 633K 599K 556K 497K 53.65M 991K 6.91M 2.56M 22.04M 2.38M 2.33M 94.97M	EV / Sales 2022	5,759,850x	EV / Sales 2023	983,765x
Free-Float	96.73%	Yield 2022 *	-	Yield 2023	-

Entheon Biomedical Corp. announced that it expects to receive CAD 0.3 million in funding	Dec. 01	CI
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024	Oct. 24	CI
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024	Jul. 04	CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024	Apr. 29	CI
Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding	Apr. 17	CI
Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding	Apr. 10	CI
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2023	Mar. 25	CI
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt	Mar. 25	CI
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	23-10-25	CI
Entheon Biomedical Corp. Announces Termination of Andrew Hegle as Chief Science Officer	23-07-31	CI
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	23-07-26	CI
Heading Health Inc. announced that it has received $4.5 million in funding from a group of investors	23-06-28	CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2023	23-04-28	CI

Entheon Biomedical : CFO Certification	22-07-26	PU
Entheon Biomedical : CEO Certification	22-07-26	PU
Entheon Biomedical : Quarterly Report	22-07-26	PU
Entheon Biomedical : CFO Certification	22-03-31	PU
Entheon Biomedical : CEO Certification	22-03-30	PU

Entheon Biomedical Corp. Stock

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Valuation: Entheon Biomedical Corp.

Chart: Entheon Biomedical Corp.

Latest news: Entheon Biomedical Corp.

Press Releases: Entheon Biomedical Corp.

News in other languages: Entheon Biomedical Corp.

Quotes and Performance

Course Extremes

Managers and Directors: Entheon Biomedical Corp.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates

IRW-News: Entheon Biomedical Corp.: HaluGen Life Sciences, eine hundertprozentige Tochtergesellschaft von Entheon Biomedical, und die Firma Silo Wellness gründen eine Partnerschaft für Psychedelika-Gentest-Kits	21-06-17
IRW-PRESS : Entheon Biomedical Corp.: HaluGen Life -2-	21-06-17
IRW-PRESS : Entheon Biomedical Corp.: HaluGen Life Sciences, eine hundertprozentige Tochtergesellschaft von Entheon Biomedical, und die Firma Silo Wellness gründen eine Partnerschaft für Psychedelika-Gentest-Kits	21-06-17
IRW-News: Entheon Biomedical Corp.: Entheon Biomedical Corp. meldet Vereinbarung zur Übernahme von Lobo Genetics Inc.	21-06-16
IRW-PRESS : Entheon Biomedical Corp.: Entheon -2-	21-06-16

1 day	+9.38%
1 week	+25.00%
Current month	+25.00%
1 month	+34.62%
3 months	+75.00%
6 months	+25.00%
Current year	+75.00%

Director	Title	Age	Since
Timothy Ko CEO	Chief Executive Officer	39	2019-06-30
Soo-Whan Kim DFI	Director of Finance/CFO	-	2023-01-06
Joseph Cullen IRC	Investor Relations Contact	41	2019-04-30

Manager	Title	Age	Since
Timothy Ko BRD	Director/Board Member	39	2020-11-04
Andrew Hegle BRD	Director/Board Member	46	2020-11-04
Christopher Gondi BRD	Director/Board Member	53	2020-11-04

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
ENTHEON BIOMEDICAL CORP.	+9.38%	+25.00%	+75.00%	-96.20%	1.01M
LONZA GROUP AG	+0.42%	-0.80%	+56.02%	-26.05%	42.72B
IQVIA HOLDINGS INC.	+1.35%	+0.89%	-6.01%	-22.98%	36.29B
CELLTRION, INC.	-0.50%	-3.69%	+12.49%	-7.48%	26.36B
ICON PUBLIC LIMITED COMPANY	+3.81%	+3.43%	-18.99%	-18.23%	17.3B
UNITED THERAPEUTICS CORPORATION	-1.26%	-0.22%	+54.04%	+95.88%	16.71B
MODERNA, INC.	+3.49%	+3.20%	-44.86%	-83.25%	16.52B
BIO-TECHNE CORPORATION	+0.84%	-1.13%	+12.83%	-36.35%	11.74B
MEDPACE HOLDINGS, INC.	+2.40%	+2.91%	+25.93%	+71.01%	10.62B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+0.14%	-3.64%	-4.42%	-45.41%	9.79B
Average	+1.83%	+0.76%	+16.20%	-16.91%	18.8B
Weighted average by Cap.	+0.92%	-0.56%	+14.47%	-12.50%